Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest plasmapheresis Stories

2014-03-24 08:28:19

BRAINTREE, Mass., March 24, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it was not selected to supply The American Red Cross with certain whole blood collection components. The Company was informed that a competitor was chosen to supply these products on an exclusive basis. Haemonetics provided the following information regarding its whole blood collection kit business with The American Red Cross: -- Haemonetics currently supplies 1.8 million in-line...

2014-03-13 23:24:08

Marine veteran Eric Sears, currently a junior majoring in sport management at Alvernia University is spending spring break in Washington D.C., donating stem cells to a fellow veteran with leukemia. Reading, PA (PRWEB) March 13, 2014 At age 25, Eric Sears has already served his country well. The Marine veteran who served four years and one deployment to Afghanistan is now back home in Reading, Pa., a junior majoring in sport management at Alvernia University. But this spring break, he is...

2013-12-27 04:21:19

DUBLIN, December 27, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/r72trl/apheresis_market) has announced the addition of the "Global Apheresis Market Report 2013-2017" [http://www.researchandmarkets.com/research/r72trl/apheresis_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Apheresis is a process wherein blood is collected and separated into different components, leveraging...

2013-12-26 12:21:11

DALLAS, Dec. 26, 2013 /PRNewswire-iReach/ -- Blood products are made by separating and extracting various proteins in plasma and classified into albumin products, immune globulin products, coagulation factor products and other blood products. China enterprises mainly produce nine kinds of products of the first three categories. (Photo: http://photos.prnewswire.com/prnh/20131226/MN38270) The concentration rate of global blood products is very high and the 5 enterprises of developed...

2013-12-24 08:24:06

DUBLIN, Ireland, December 24, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/n9msnn/apheresis) has announced the addition of the "Global Apheresis Equipment Market 2013 - 2018" [http://www.researchandmarkets.com/research/n9msnn/apheresis ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report on the global apheresis equipment market includes the different facets of therapeutic...

2013-11-19 12:30:01

BOCA RATON, Fla., Nov. 19, 2013 /PRNewswire/ -- Biotest Pharmaceuticals Corporation ("Biotest"), a wholly owned US subsidiary of Biotest AG, (Dreieich Germany), announced today that it has been awarded the 2013 International Business Leadership Award for "Business Expansion" from the Greater Miami Chamber of Commerce. This award recognizes companies that uniquely focus on retaining and growing existing international business relationships and whose activities provide a significant...

2013-11-12 16:25:19

DURHAM, N.C., Nov. 12, 2013 /PRNewswire/ -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis(TM) technology platform, today announced that Jeff Abbey, president and chief executive officer, is scheduled to present at the Elsevier Therapeutic Area Partnerships Meeting on November 19 at the Hyatt Regency Boston. Event:...

2013-11-11 04:21:24

BARCELONA, Spain, Nov. 11, 2013 /PRNewswire/ -- -- The assets acquired include in vitro diagnostic products and technology for transfusion medicine and immunology, a manufacturing plant in the USA and commercial offices in United States, Switzerland and Hong Kong -- Following the acquisition, Grifols' Diagnostic Division will account for over 20% of the company's sales, with an estimated turnover close to US$ 1.0 billion -- This acquisition...

2013-10-30 15:35:50

Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload. In a study published recently in Molecular Therapy, researchers found that giving subjects a treatment to temporarily rid the body of antibodies provides the virus safe passage to targeted cells, allowing it to release a...

2013-10-15 08:31:20

CSL Plasma and CSL Behring celebrate International Plasma Awareness Week with week-long activities and the opening of a plasma center in Vancouver, Wash. KING OF PRUSSIA, Pa., Oct. 15, 2013 /PRNewswire/ -- CSL Plasma, operator of one of the largest plasma collection networks in the world and parent company CSL Behring are celebrating the contributions of donor-heroes during International Plasma Awareness Week (IPAW), October 13-20. The week-long observance, which is sponsored by the...